Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Herpes Zoster Vaccine [Phase 1, Phase 2]

View source ↗

Summary

This document provides an update on a Phase 1/2 study evaluating a recombinant herpes zoster vaccine developed by Sinocelltech Ltd. The trial is not yet recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• Recombinant Herpes Zoster Vaccine

Snippet

Sponsor: Sinocelltech Ltd. | Conditions: Herpes Zoster | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING